The identification of complement C1q and/or C3 proteins might suggest MGRS-related lesions such as PGNMIDs, immunotactoid glomerulonephritis, cryoglobulinemia glomerulonephritis, C3 glomerulopathy, or heavy chain and light chain deposition diseases. This evidence concerns the gene C3 and complement 3 glomerulopathy.